Patents by Inventor Mark Terrell Smith

Mark Terrell Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200376090
    Abstract: This invention generally relates to pharmaceutical compositions for use in the treatment of pain and inflammation, the prevention and improvement of symptoms of musculoskeletal distress degeneration, including temporary loss of range of motion, temporary inflammation, temporary muscle soreness, and combinations thereof, to assist recovery following exercise and recovery of muscles and joints therefrom, and to provide relief of such symptoms in a mammalian organism, said compositions comprising: (i) an analgesically and anti-inflammatory effective amount of a undenatured cartilage including an isolated native Type II collagen; and (ii) an analgesically and antitussively effective amount of at least one non-steroidal anti-inflammatory agent including aspirin, celecoxib, diclofenac, ibuprofen, indomethacin, naproxen, oxaprozin and piroxicam, or a therapeutically active stereoisomer thereof substantially free of its other stereoisomers; and optionally (iii) a pharmaceutically acceptable amount of at least one exc
    Type: Application
    Filed: May 29, 2019
    Publication date: December 3, 2020
    Applicant: Performacne By Science, LLC
    Inventor: Mark Terrell Smith
  • Publication number: 20200282023
    Abstract: The present invention relates generally to compositions and methods of using compositions comprised of undenatured cartilage in the form of an isolated native Type II collagen that may be combined in a synergistic blend with one or more edible metals with acceptable chemical counter-ions or other health promoting ingredients to be orally consumed as a method for preventing and improving symptoms of musculoskeletal distress degeneration, including symptoms selected from temporary loss of range of motion, temporary inflammation, temporary muscle soreness, and combinations thereof. The synergistic compositions of the present invention also protect, promote and improve recovery from and prevention of cartilage and ligament wear, thinning and damage to bone, and repetitive motion injuries and stress resulting from intense periods of activity or workout routines that contribute to such musculoskeletal distress degeneration symptoms.
    Type: Application
    Filed: March 8, 2019
    Publication date: September 10, 2020
    Inventor: Mark Terrell Smith
  • Patent number: 10226513
    Abstract: The present invention relates generally to compositions and methods of using compositions comprised of undenatured cartilage in the form of an isolated native Type II collagen that may be combined in a synergistic blend with one or more edible metals with acceptable chemical counter-ions or other health promoting ingredients to be orally consumed as a method for preventing and improving symptoms of musculoskeletal distress degeneration, including symptoms selected from temporary loss of range of motion, temporary inflammation, temporary muscle soreness, and combinations thereof. The synergistic compositions of the present invention also protect, promote and improve recovery from and prevention of cartilage and ligament wear, thinning and damage to bone, and repetitive motion injuries and stress resulting from intense periods of activity or workout routines that contribute to such musculoskeletal distress degeneration symptoms.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: March 12, 2019
    Inventor: Mark Terrell Smith
  • Publication number: 20160199456
    Abstract: The present invention relates generally to compositions and methods of using compositions comprised of undenatured cartilage in the form of an isolated native Type II collagen that may be combined in a synergistic blend with one or more edible metals with acceptable chemical counter-ions or other health promoting ingredients to be orally consumed as a method for preventing and improving symptoms of musculoskeletal distress degeneration, including symptoms selected from temporary loss of range of motion, temporary inflammation, temporary muscle soreness, and combinations thereof. The synergistic compositions of the present invention also protect, promote and improve recovery from and prevention of cartilage and ligament wear, thinning and damage to bone, and repetitive motion injuries and stress resulting from intense periods of activity or workout routines that contribute to such musculoskeletal distress degeneration symptoms.
    Type: Application
    Filed: January 7, 2016
    Publication date: July 14, 2016
    Inventor: Mark Terrell Smith